MIRA INFORM REPORT

 

 

Report Date :

12.07.2014

 

IDENTIFICATION DETAILS

 

Name :

PLASMAGEN BIOSCIENCES PRIVATE LIMITED

 

 

Registered Office :

No. 160, KCI Chambers, 2nd Floor, 5th Main Road, Chamarajpet, Bangalore – 560018, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

07.09.2010

 

 

Com. Reg. No.:

08-055077

 

 

Capital Investment / Paid-up Capital :

Rs. 10.000 Millions

 

 

CIN No.:

[Company Identification No.]

U51909KA2010PTC055077

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Plasma based Pharmaceuticals Products.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (16)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track record.

 

Networth of the company has been eroded due to continuous accumulated loss incurred from its operations.

 

However, business is active. Payment terms are reported to be slow.

 

The company can be considered for business dealings on safe and secured trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

The economy grew 4.7 %in 2013/14, marking a second straight year of sub-5 % growth – the worst slowdown in more than a quarter of a century. The data was below an official estimate of 4.9 % annual growth and compared with 4.5 % in the last fiscal year. However, the current account deficit narrowed sharply to $ 32.4 billion at 1.7 % of gross domestic product, in 2013/14 from a record high of $ 98.8 billion or 4.7 %, the year before.A sharp fall in gold imports due to restrictions on overseas purchases and muted import of capital goods helped shrink the current account deficit.

 

Online retailer Flipkart has acquired fashion portal Myntra as it prepares to battle with the rapidly expanding India arm of the global e-commerce giant Amazon. The company raised $ 210 million from Russian Investment firm DST Global which has also invested in companies like Facebook, Twitter and Alibaba Group.

 

General Motors will start exporting vehicles from its Talegaon plant near Pune in the second half of 2014. GM was one of the few global carmakers that was using its India plant only for the domestic market.

 

Google has overtaken Apple as the world’s top brand in terms of value, according to global market research agency Millward Brown. Google’s brand value shot up 40 % in a year to $ 158.84 billion. The top 10 of the 100 slots were dominated by US companies.

 

Infosys lost another heavy weight when B G Srinivas, a board member put in his papers. He is the third CEO-hopeful to quit after Chairman N R Narayana Murthy’s return to the company – Ashok Vemuri and V Balakrishnan being the other two.While Vemuri went on to lead IGate, Balakrishnan joined politics.

 

Naresh Goyal – promoted Jet Airways posted biggest quarterly loss – Rs 2153.37 crore – in the three months ended March 31, mainly because it has been offering discounts to passengers to fill planes.

 

William S Pinckney – Chairman and CEO of Amway India was arrested by the Andhra Pradesh Police in connection with a complaint against the direct selling firm. This is the second time that he has been taken into custody. A year, ago the Kerala Police had arrested Pinckney and two company directors on charges of financial irregularities.

 

China has told its state-owned enterprises to sever links with American consulting firms after the United States charged five Chinese military officers wih hacking US companies. China’s action which targets consultancies like McKinsey & Co. and the Boston Consulting Group, sterns from fears that the first are providing trade secrets to the US governments.

 

India has emerged as a country with some of the highest unregistered businesses in the world. Indonesia has the maximum number of shadow businesses, says a study of 68 countries by Imperial College Business School in London.

 

Pfizer has abandoned its attempt to buy AstraZeneca for nearly $ 118 billion after the latter refused an offer of 55 pounds a share.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE

 

(CONTACT NO.: 91-80-42154535/ 36)

 

 

LOCATIONS

 

Registered Office :

No. 160, KCI Chambers, 2nd Floor, 5th Main Road, Chamarajpet, Bangalore – 560018, Karnataka, India

Tel. No.:

91-80-42154535/ 36

Fax No.:

91-80-42154537

E-Mail :

vinod@plasmagen.in

info@plasmagen.in

Website :

http://www.plasmagen.in

 

 

Plasma Storage Center :

No. 1342, Ground Floor, Dr. Shivaramakaranth Nagar, MCEHS Layout, Venkateshwara Nagar Main Road, Yelahanka Hobli, Bangalore – 560064, Karnataka, India

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Vinod Nahar

Designation :

Director

Address :

121 Bull Temple Road Cross, Opposite Maratha Hostel, Bangalore - 560019, Karnataka, India

Date of Birth/Age :

12.08.1974

Date of Appointment :

07.09.2010

DIN No.:

01562249

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110KA1989PTC009974

R S M PHARMA PRIVATE LIMITED

Director

25/09/2007

17/01/2001

-

Active

NO

2

U24231KA2004PTC034182

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

Managing director

07/08/2008

22/06/2004

-

Active

NO

3

U24239KA2007PTC043662

EUGENE BIOSCIENCES PRIVATE LIMITED

Director

22/08/2007

22/08/2007

-

Active

NO

4

U51909KA2010PTC054101

FRISIA HEALTHCARE SERVICES PRIVATE LIMITED

Director

17/06/2010

17/06/2010

-

Active

NO

5

U51909KA2010PTC055077

PLASMAGEN BIOSCIENCES PRIVATE LIMITED

Director

07/09/2010

07/09/2010

-

Active

NO

6

U51397KA2010PTC055190

SPLENDINA HEALTHCARE PRIVATE LIMITED

Director

17/09/2010

17/09/2010

-

Active

NO

7

U51900KA2011PTC056703

RSM LIFECARE INDIA PRIVATE LIMITED

Director

19/01/2011

19/01/2011

-

Active

NO

8

U52300KA2012PTC065974

HOSPITALIS SUPPLY SOLUTIONS PRIVATE LIMITED

Director

24/09/2012

24/09/2012

14/01/2014

Active

NO

 

 

Name :

Mr. Kapil Kumar Bhawarlal Jain

Designation :

Director

Address :

# 92 H.B. Samaja Road, Basavanagudi, Bangalore – 560004, Karnataka, India

Date of Birth/Age :

29.09.1983

Date of Appointment :

07.09.2010

DIN No.:

01597267

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231KA2004PTC034182

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

Director

18/06/2007

18/06/2007

Active

NO

2

U51909KA2010PTC055077

PLASMAGEN BIOSCIENCES PRIVATE LIMITED

Director

07/09/2010

07/09/2010

Active

NO

3

U24100TN2014PTC094601

VEROGEN HEALTHCARE PRIVATE LIMITED

Director

16/01/2014

16/01/2014

Active

NO

 

 

Name :

Mr. Ranjeet Mohan Ajmani

Designation :

Director

Address :

St. John Woods, Flat No.808, Deodar Block, Tavarekere Main Road, Koramangala, Bangalore - 560029, Karnataka, India

Date of Birth/Age :

07.10.1963

Date of Appointment :

28.09.2012

DIN No.:

05132986

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U51909KA2010PTC055077

PLASMAGEN BIOSCIENCES PRIVATE LIMITED

Director

28/09/2012

19/12/2011

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

 

No. of Shares

 

Vinod Nahar

 

250000

Bhwarlal Jain

 

50000

Chirag Bohra

 

10000

Dinesh Kumar

 

50000

Ganpathlal

 

50000

Kapil Kumar Jain

 

50000

Rahul Jain

 

50000

Rahul K Jain

 

20000

Sonu Dantewadia

 

50000

Unnati Polymers Private Limited

 

170000

Vijay Nahar

 

250000

 

 

 

Total

 

 

1000000

 

 

AS ON 30.09.2013

 

Equity Share Breakup

Percentage of Holding

Category

 

Bodies corporate

17.00

Directors or relatives of directors

83.00

 

 

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Plasma based Pharmaceuticals Products.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         HDFC Bank Limited

HDFC Bank House, Senapati Bapat Marg, Lower Parel [West], Mumbai - 400013, Maharashtra, India

 

·         Bank of India

HSBC Bank

 

 

Facilities :

 

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

From Banks

- Bank O/D – HDFC Bank Limited – CC

2.450

0.000

 

 

 

Total

 

2.450

0.000

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Rishi R Jain

Chartered Accountant

Address :

No 5, Vishwanath Rao Road, Ground Floor, Madhavnagar, Bangalore – 560001, Karnataka, India

Tel. No.:

91-80-41266917

Income-tax PAN of auditor or auditor's firm :

ABZPB5750E

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,000,000

Equity Shares

Rs. 10/- each

Rs. 10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,000,000

Equity Shares

Rs. 10/- each

Rs. 10.000 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

10.000

10.000

0.100

(b) Reserves & Surplus

(21.777)

(4.125)

(1.655)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

15.000

15.000

0.000

Total Shareholders’ Funds (1) + (2)

3.223

20.875

(1.555)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

40.550

5.968

1.237

(b) Deferred tax liabilities (Net)

0.078

0.015

0.005

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

40.628

5.983

1.242

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

2.450

0.000

0.000

(b) Trade payables

21.960

6.567

0.000

(c) Other current liabilities

0.761

0.516

0.006

(d) Short-term provisions

7.191

3.226

0.596

Total Current Liabilities (4)

32.362

10.309

0.602

 

 

 

 

TOTAL

76.213

37.167

0.289

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

5.321

1.083

0.066

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

5.321

1.083

0.066

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

27.390

19.888

0.000

(c) Trade receivables

12.879

5.162

0.000

(d) Cash and cash equivalents

0.610

0.011

0.196

(e) Short-term loans and advances

8.530

3.622

0.017

(f) Other current assets

2.588

0.575

0.010

Total Current Assets

51.997

29.258

0.223

 

 

 

 

Preliminary Expenses/Deferred Revenue Expenses

18.895

6.826

0.000

 

 

 

 

TOTAL

76.213

37.167

0.289

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

TOTAL                                    

110.881

30.066

0.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL            

128.469

32.528

1.649

 

 

 

 

 

 

PROFIT/ [LOSS] BEFORE TAX

(17.588)

(2.462)

(1.649)

 

 

 

 

 

Less

TAX                                                                 

0.064

0.008

0.006

 

 

 

 

 

 

PROFIT/ [LOSS] AFTER TAX

(17.652)

(2.470)

(1.655)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

0.719

0.000

0.000

 

 

 

 

 

 

Earnings/ [Loss] Per Share (Rs.)

(17.65)

(2.47)

(165.50)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

(15.92)

(8.22)

0.00

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(30.68)

(8.11)

(570.59)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(5.46)

(0.12)

1.06

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

13.34

0.29

(0.80)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.61

2.84

0.37

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

0.100

10.000

10.000

Reserves & Surplus

(1.655)

(4.125)

(21.777)

Share Application money pending allotment

0.000

15.000

15.000

Net worth

(1.555)

20.875

3.223

 

 

 

 

long-term borrowings

1.237

5.968

40.550

Short term borrowings

0.000

0.000

2.450

Total borrowings

1.237

5.968

43.000

Debt/Equity ratio

(0.795)

0.286

13.342

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

0.000

30.066

110.881

 

 

 

268.792

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

0.000

30.066

110.881

Profit/ [Loss]

(1.655)

(2.470)

(17.652)

 

 

(8.22%)

(15.92%)

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10412817

30/01/2013

2,500,000.00

HDFC BANK LIMITED

HDFC BANK HOUSE SENAPATI BAPAT MARG, LOWER PAREL W, MUMBAI, MAHARASHTRA - 400013, INDIA

B71143077

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Loans from Others

Unsecured loans from shareholders, directors and relatives 

40.550

5.968

 

 

 

Total

 

40.550

5.968

 

 

BUSINESS REVIEW

 

The Company is a young biopharmaceutical Company, working in the field of “Transfusion Medicine”, which includes operation of blood centres and plasma fractionation. Their aim is to achieve self-sufficiency in blood/plasma products in India and SAARC nations and grow globally.

 

 

FIXED ASSETS:

 

·         Computer, Software and Peripherals

Office Equipments

Furniture and Fixture

Leasehold Improvement

Cold Storage

Computer

Vehicles


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.19

UK Pound

1

Rs. 103.15

Euro

1

Rs. 81.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

2

--RESERVES

1~10

1

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

16

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.